The Utility of Long-Read Sequencing in Diagnosing Genetic Autosomal Recessive Parkinson's Disease: a genetic screening study
Daida, K.; Yoshino, H.; Malik, L.; Baker, B.; Ishiguro, M.; Genner, R.; Paquette, K.; Li, Y.; Nishioka, K.; Masuzugawa, S.; Hirano, M.; Takahashi, K.; Kolmogolv, M.; Billingsley, K. J.; Funayama, M.; Blauwendraat, C.; Hattori, N.
Show abstract
BackgroundMutations within the genes PRKN and PINK1 are the leading cause of early onset autosomal recessive Parkinsons disease (PD). However, the genetic cause of most early-onset PD (EOPD) cases still remains unresolved. Long-read sequencing has successfully identified many pathogenic structural variants that cause disease, but this technology has not been widely applied to PD. We recently identified the genetic cause of EOPD in a pair of monozygotic twins by uncovering a complex structural variant that spans over 7 Mb, utilizing Oxford Nanopore Technologies (ONT) long-read sequencing. In this study, we aimed to expand on this and assess whether a second variant could be detected with ONT long-read sequencing in other unresolved EOPD cases reported to carry one heterozygous variant in PRKN or PINK1. MethodsONT long-read sequencing was performed on patients with one reported PRKN/PINK1 pathogenic variant. EOPD patients with an age at onset younger than 50 were included in this study. As a positive control, we also included EOPD patients who had already been identified to carry two known PRKN pathogenic variants. Initial genetic testing was performed using either short-read targeted panel sequencing for single nucleotide variants and multiplex ligation-dependent probe amplification (MLPA) for copy number variants. Results48 patients were included in this study (PRKN "one-variant" n = 24, PINK1 "one-variant" n = 12, PRKN "two-variants" n = 12). Using ONT long-read sequencing, we detected a second pathogenic variant in six PRKN "one-variant" patients (26%, 6/23) but none in the PINK1 "one-variant" patients (0%, 0/12). Long-read sequencing identified one case with a complex inversion, two instances of structural variant overlap, and three cases of duplication. In addition, in the positive control PRKN "two-variants" group, we were able to identify both pathogenic variants in PRKN in all the patients (100%, 12/12). ConclusionsThis data highlights that ONT long-read sequencing is a powerful tool to identify a pathogenic structural variant at the PRKN locus that is often missed by conventional methods. Therefore, for cases where conventional methods fail to detect a second variant for EOPD, long-read sequencing should be considered as an alternative and complementary approach.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Long-read sequencing unravels the complexity of structural variants in PRKN in two individuals with early-onset Parkinson's disease 95%
- The non-coding GBA1 rs3115534 variant is associated with REM sleep behavior disorder in Nigerians 94%
- Classification of GBA1 variants in Parkinson’s disease; the GBA1 -PD browser 93%
Similar papers in this journal
- Asymptomatic carriers of the p.A53T SNCA mutation: data from the PPMI study 94%
- MAPT allele and haplotype frequencies in Nigerian Africans: population distribution and association with Parkinson’s disease risk and age at onset 93%
- impaired bed mobility in prediagnostic and de novo Parkinson’s disease 93%
Similar papers in this journal
- Rare PSAP variants and possible interaction with GBA in REM sleep behavior disorder 95%
- Vagus Nerve and Stomach Synucleinopathy in Parkinson’s Disease, Incidental Lewy Body Disease and Normal Elderly Subjects: Evidence Against the “Body-First” Hypothesis 93%
- Slow Motion Analysis of Repetitive Tapping (SMART) test: measuring bradykinesia in recently diagnosed Parkinson’s disease and idiopathic anosmia 93%
Similar papers in this journal
- Improved detection of SBDS gene mutation by a new method of next-generation sequencing analysis based on the Chinese mutation spectrum 94%
- Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease 93%
- Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.